Use this button to switch between dark and light mode.

Investigational New Drug (IND) Clinical Trial Holds

June 11, 2025 (1 min read)

This practice note discusses FDA clinical hold orders issued to IND sponsors and covers grounds for issuing a clinical hold order, how the FDA issues an order, and how a sponsor should respond to a clinical hold order to ensure a timely review.

Read now »

Related Content

Practical Guidance Updates
Featuring the latest updates from your Practical Guidance account.

  • Trump Transition Coverage in Practical Guidance
    The Trump Transition Resource Kit is a consolidated listing of guidance related to new actions and orders, and the Presidential Executive Actions Tracker is a frequently updated listing and description of many of the recently implemented presidential orders and rescissions of previous administration orders.
  • New! Practical Guidance Journal, 2025 Second Edition features guidance for regulating AI in the workplace in 2025, Intellectual Property issues related to deepfakes, the emergence of AI in mergers and acquisitions, and a checklist to help when evaluating AI technology risks.
  • Review the Chevron Reversal Impact Resource Kit for analysis related to the Supreme Court’s decision to overturn four decades of deference to federal agency interpretations of ambiguous statutes.
  • Browse the Practical Guidance Author Center to see the 2600+ leading attorney authors contributing to our 26 practice areas. Interested in becoming a Practical Guidance author? Click here for details. Practical Guidance is committed to amplifying diverse voices of attorneys across all differences, including gender and race.

PRACTICAL GUIDANCE CUSTOMER EMAIL EDITION ON THE WEB

Experience results today with practical guidance, legal research, and data-driven insights—all in one place.

Experience Lexis+